Automatic Bevacizumab Response Prediction in Ovarian Cancer from Digital Pathology Images via Novel AI-based Computational Pipeline

Ovarian cancer is a gynecological cancer, which, if metastasized and not detected early, can cause death among women. Therefore, accurate prediction of drug responses to ovarian cancer is needed. A gynecological pathologist inspects abnormality in tissues and provides a report for patients; however, this diagnostic process (1) is difficult to undertake; (2) requires experience; and (3) is time-consuming. Moreover, existing tools are imperfect. Hence, we present a computational pipeline to improve predictions of drug response pertaining to ovarian cancer. First, we downloaded digital pathology images pertaining to ovarian responses to bevacizumab from the Cancer Imaging Archive Repository. We employed a histogram of oriented gradients for images, constructed feature vectors, and used Fisher’s linear discriminant analysis to alter data representations through dimensionality reduction. This reduced-dimensionality data was used for regression analysis, employing support vector regression coupled with various kernels and calculating the area under the ROC curve (AUC). Experimental results were validated using transformerbased models (ViT and Swin) and other deep learning (DL) models (VGG16, ResNet50, InceptionV3, MobileNetV2, and EfficientNetB6). Our approach using a radial kernel (named SVRD+R) improved AUC performance by 17% compared to the best-performing transformer-based model (ViT). Likewise, AUC performance improved by 14.9% when compared against the best DL-based model (MobileNetV2). These results demonstrate feasibility, showing that induced models via the presented AI-based pipeline can lead to superior performance when investigating prediction problems pertaining to gynecologic cancer studies. MSC 92B05; 68T09